168 related articles for article (PubMed ID: 37002245)
1. Identification of osteosarcoma m6A-related prognostic biomarkers using artificial intelligence: RBM15.
Jiang J; Qu H; Zhan X; Liu D; Liang T; Chen L; Huang S; Sun X; Chen J; Chen T; Li H; Yao Y; Liu C
Sci Rep; 2023 Mar; 13(1):5255. PubMed ID: 37002245
[TBL] [Abstract][Full Text] [Related]
2. Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma.
Zhang P; Xu K; Wang J; Zhang J; Quan H
BMC Cancer; 2021 Dec; 21(1):1285. PubMed ID: 34852770
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
4. Two novel predictive biomarkers for osteosarcoma and glycolysis pathways: A profiling study on HS2ST1 and SDC3.
Yang G; Jiang J; Yin R; Li Z; Li L; Gao F; Liu C; Zhan X
Medicine (Baltimore); 2022 Sep; 101(36):e30192. PubMed ID: 36086752
[TBL] [Abstract][Full Text] [Related]
5. m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
Zhang W; Wang L; Zhang P; Zhang Q
Medicine (Baltimore); 2021 May; 100(20):e25952. PubMed ID: 34011074
[TBL] [Abstract][Full Text] [Related]
6. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.
Liu H; Qin G; Ji Y; Wang X; Bao H; Guan X; Wei A; Cai Z
J Orthop Surg Res; 2021 May; 16(1):294. PubMed ID: 33952279
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
Wu ZY; Shi ZY
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
[TBL] [Abstract][Full Text] [Related]
8. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
9. Identification of Prognostic RBPs in Osteosarcoma.
Li B; Fang L; Wang B; Yang Z; Zhao T
Technol Cancer Res Treat; 2021; 20():15330338211004918. PubMed ID: 33754909
[TBL] [Abstract][Full Text] [Related]
10. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
[TBL] [Abstract][Full Text] [Related]
11. Experimental validation and comprehensive analysis of m6A methylation regulators in intervertebral disc degeneration subpopulation classification.
Xu X; Shen L; Qu Y; Li D; Zhao X; Wei H; Yue S
Sci Rep; 2024 Apr; 14(1):8417. PubMed ID: 38600232
[TBL] [Abstract][Full Text] [Related]
12. Risk Score Prediction Model of Prognosis in GC Patients by Age and Gender Combined With m6A Modification Genes FTO and RBM15.
Yue L; Zhang R; Chen S; Duan G
Front Cell Dev Biol; 2022; 10():710708. PubMed ID: 35433701
[No Abstract] [Full Text] [Related]
13. Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma.
Tian L; Wang Y; Tian J; Song W; Li L; Che G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047493
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
Lei T; Qian H; Lei P; Hu Y
Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
[TBL] [Abstract][Full Text] [Related]
15. Circ-CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15.
Yang F; Liu Y; Xiao J; Li B; Chen Y; Hu A; Zeng J; Liu Z; Liu H
Cell Prolif; 2023 Jan; 56(1):e13344. PubMed ID: 36181462
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
Front Genet; 2022; 13():872186. PubMed ID: 35937991
[No Abstract] [Full Text] [Related]
17. Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma.
Chen Y; Zhao B; Wang X
BMC Cancer; 2020 Oct; 20(1):1022. PubMed ID: 33087099
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
Fu Y; Sun S; Bi J; Kong C; Yin L
Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886
[TBL] [Abstract][Full Text] [Related]
19. Novel prognostic biomarkers, METTL14 and YTHDF2, associated with RNA methylation in Ewing's sarcoma.
Jiang J; Fan Q; Qu H; Liu C; Liang T; Chen L; Huang S; Sun X; Chen J; Chen T; Li H; Yao Y; Zhan X
Sci Rep; 2022 Apr; 12(1):7041. PubMed ID: 35487915
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
